Natco Pharma Limited — Apixaban Exporter Profile
Indian Pharmaceutical Exporter · #6 for Apixaban · $3.6M export value · DGFT Verified
Natco Pharma Limited is the #6 Indian exporter of Apixaban with $3.6M in export value and 72 verified shipments. Natco Pharma Limited holds a 2.0% market share in Apixaban exports across 7 countries. The company exports 17 pharmaceutical products worth $36.0M across 6 therapeutic categories.
Natco Pharma Limited — Apixaban Export Profile: Buyers & Destinations
Where Does Natco Pharma Limited Export Apixaban?
| Country | Value | Shipments | Share |
|---|---|---|---|
| BRAZIL | $932.4K | 19 | 42.3% |
| CANADA | $523.1K | 18 | 23.7% |
| MYANMAR | $386.9K | 11 | 17.6% |
| PHILIPPINES | $150.5K | 10 | 6.8% |
| THAILAND | $129.0K | 7 | 5.9% |
| SAUDI ARABIA | $68.0K | 5 | 3.1% |
| BOTSWANA | $14.4K | 2 | 0.7% |
Natco Pharma Limited exports Apixaban to 7 countries. The largest destination is BRAZIL accounting for 42.3% of Natco Pharma Limited's Apixaban shipments, followed by CANADA (23.7%) and MYANMAR (17.6%). These destinations reflect Natco Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Apixaban from Natco Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| NATCOFARMA DO BRASIL LTDA | BRAZIL | $582.4K | 12 |
| ABC INTERNATIONAL LTD | MYANMAR | $386.9K | 11 |
| NATCO PHARMA (CANADA) INC | CANADA | $332.1K | 14 |
| NATCOFARMA DO BRASIL LTDA, | BRAZIL | $300.0K | 6 |
| NATCO PHARMA (CANADA)INC | CANADA | $141.3K | 3 |
| NATCO LIFESCIENCES PHILIPPINES INC | PHILIPPINES | $81.4K | 7 |
| NATCO LIFESCIENCES PHILIPPINES INC, | PHILIPPINES | $69.1K | 3 |
| BOSTON ONCOLOGY ARABIA | SAUDI ARABIA | $68.0K | 5 |
| NATCOFARMA DO BRASIL LIMITED A AV QUINHENTOS N | BRAZIL | $50.0K | 1 |
| ABC INTERNATIONAL LIMITED | THAILAND | $50.0K | 1 |
Natco Pharma Limited supplies Apixaban to 15 buyers globally. The largest buyer is NATCOFARMA DO BRASIL LTDA (BRAZIL), followed by ABC INTERNATIONAL LTD (MYANMAR) and NATCO PHARMA (CANADA) INC (CANADA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Apixaban Export Value and How Much Does Natco Pharma Limited Contribute?
India exported $85.0M worth of Apixaban through 4,492 shipments from 171 suppliers to 98 countries, serving 371 buyers globally. Natco Pharma Limited contributes $3.6M to this total, accounting for 2.0% of India's Apixaban exports. Natco Pharma Limited ships Apixaban to 7 countries through 15 buyers.
What Is the Average Shipment Value for Natco Pharma Limited's Apixaban Exports?
Natco Pharma Limited's average Apixaban shipment value is $50.0K per consignment, based on 72 shipments totaling $3.6M. The largest destination is BRAZIL (42.3% of Natco Pharma Limited's Apixaban exports).
How Does Natco Pharma Limited Compare to Other Indian Apixaban Exporters?
Natco Pharma Limited ranks #6 among 171 Indian Apixaban exporters with a 2.0% market share. The top 3 exporters are INTAS PHARMACEUTICALS LIMITED ($18.7M), APOTEX RESEARCH PRIVATE LIMITED ($18.1M), SANDOZ PRIVATE LIMITED ($15.6M). Natco Pharma Limited processed 72 shipments to 7 destination countries.
What Apixaban Formulations Does Natco Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| APIXABAN 2.5MG TABLETS 60'S (APPENDIX 4R | $150.0K | 3 |
| APIXABAN 2.5MG TABLETS 20'S (APPENDIX 4R | $132.4K | 3 |
| NAT-APIXABAN 2.5 MG TABLETS 60'S(23580X60'S) (APPENDIX 4R, RODTEP ENTRY NO:10153)(OTHER REFERENCE(S) CI NO:124023) | $129.2K | 3 |
| APIXABAN 5MG TABLETS 60'S (APPENDIX 4R, | $100.0K | 2 |
| APIXABAN 5MG TABLETS 20'S (APPENDIX 4R, | $100.0K | 2 |
| NAT-APIXABAN 5MG TABLETS 60'S (9120X60'S)(APPENDIX 4R, RODTEP ENTRY NO:10153)(OTHER REFERENCE(S)CI NO:123238)NOS | $61.9K | 3 |
| APIXABAN 2.5MG TABLETS 60'S (OTHER REFER | $58.2K | 2 |
| APIXABAN 2.5MG TABLES 30'S (26444X30'S )(ALONG WITH 2646 BLISTERS OF FREE SAMPLES)NOS | $58.2K | 3 |
| NAT-APIXABAN 2.5MG TABLETS 60'S (OTHER R | $50.0K | 1 |
| NAT-APIXABAN 5MG TABLETS 180'S (OTHER RE | $50.0K | 1 |
Natco Pharma Limited exports 49 distinct Apixaban formulations including tablets, capsules, syrups, and combination drugs. The top formulation is APIXABAN 2.5MG TABLETS 60'S (APPENDIX 4R with 3 shipments worth $150.0K.
Regulatory Requirements: Exporting Apixaban to Key Markets
What Natco Pharma Limited must comply with to export Apixaban to its top destination countries
Brazil — ANVISA
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Natco Pharma Limited Compare to Nearest Apixaban Exporters?
Exporters ranked immediately above and below #6 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | MACLEODS PHARMACEUTICALS LTD | $4.3M | 85 | 9 | $50.0K |
| 8 | UNISON PHARMACEUTICALS PRIVATE LIMITED | $3.9M | 114 | 5 | $34.2K |
| 6 | NATCO PHARMA LIMITED ★ | $3.6M | 72 | 7 | $50.0K |
| 7 | MICRO LABS LIMITED | $3.4M | 68 | 14 | $50.0K |
| 9 | EMCURE PHARMACEUTICALS LIMITED | $3.0M | 122 | 2 | $24.4K |
Natco Pharma Limited ranks #6 among 171 Indian Apixaban exporters. Average shipment value of $50.0K compared to the market average of $497.1K. The closest competitors by value are MACLEODS PHARMACEUTICALS LTD and UNISON PHARMACEUTICALS PRIVATE LIMITED.
Which Indian Ports Ship Apixaban Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 724 | 16.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 674 | 15.0% |
| DELHI AIR CARGO ACC (INDEL4) | 607 | 13.5% |
| DELHI AIR | 364 | 8.1% |
| MUNDRA SEA | 146 | 3.3% |
| Bombay Air | 134 | 3.0% |
| JNPT/ NHAVA SHEVA SEA | 131 | 2.9% |
| AHEMDABAD AIR ACC (INAMD4) | 129 | 2.9% |
What Other Cardiovascular Products Does Natco Pharma Limited Export?
Natco Pharma Limited also exports these cardiovascular products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Natco Pharma Limited's Apixaban Exports
Natco's export operations are currently navigating a complex geopolitical landscape. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. These challenges are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and supply chain management. (pharmaceuticalcommerce.com)
In the United States, recent tariff implementations have introduced additional complexities for Indian pharmaceutical exporters. The U.S. administration's imposition of tariffs on imports from various countries, including India, has raised concerns about the competitiveness of Indian generics in the U.S. market. These tariffs could potentially erode profit margins and affect pricing strategies. (apnews.com)
Conversely, the European Union's stringent regulatory changes, such as the Falsified Medicines Directive, have heightened compliance requirements for exporters. While these regulations aim to ensure product authenticity and safety, they also necessitate significant investments in serialization and traceability systems. For companies like Natco, adhering to these standards is crucial for maintaining access to the lucrative EU market.
Natco Pharma Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing intensified scrutiny regarding quality and compliance. The U.S. Food and Drug Administration (FDA) has increased inspections of Indian manufacturing facilities, emphasizing adherence to Good Manufacturing Practices (GMP). Non-compliance can lead to warning letters, import alerts, or even bans, posing significant risks to exporters. (fact.net.in)
Natco's commitment to quality is evident in its proactive measures to meet international standards. The company's recent product approvals and successful market entries suggest a robust compliance framework. However, continuous vigilance and investment in quality systems are imperative to navigate the evolving regulatory landscape and to sustain export growth.
About Natco Pharma Limited
Natco Pharma Limited exports 17 products worth $36.0M. Beyond Apixaban, top products include Everolimus, Oseltamivir, Anastrozole, Ondansetron, Imatinib. View the complete Natco Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Apixaban — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Apixaban shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Natco Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 72 individual customs records matching Natco Pharma Limited exporting Apixaban, covering 49 formulations to 7 countries via 15 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 98+ countries, 371+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Apixaban Export Data from Natco Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Natco Pharma Limited's Apixaban exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Natco Pharma Limited
Full Company Profile →
17 products · $36.0M total trade · 6 categories
Apixaban Stats
Company Overview
Top Products by Natco Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Natco Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Apixaban. For current shipment-level data, contact TransData Nexus.